Internal Medicine, Endocrinology, Diabetes, & Metabolism · Mount Kisco, NY
NPI
1306899745
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
90 S Bedford Rd, Care Mount Medical PC
Mount Kisco, NY, 10549
Phone (914) 241-1050
Groups this clinician bills Medicare through
Medicare paid, 2024
$420K
17,440 services
Medicare patients, 2024
875
Average age 75
Drug cost, 2024
$3.5M
8,799 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chee-Yeung Chan was code J0897 (injection, denosumab, 1 mg), 10,080 times for 101 patients. In total Chee-Yeung Chan billed 17,440 services in 63 codes, and Medicare paid $420K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 10,080 | 101 | $20.59 | $207K |
| 99214 Office E&M - Established | Office | 1,140 | 708 | $102.21 | $117K |
| 36415 Venipuncture Blood Collection | Office | 925 | 610 | $8.63 | $7,983 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 802 | 567 | $14.26 | $11K |
| 80053 Clinical Chemistry | Office | 416 | 307 | $10.33 | $4,298 |
| 83036 Blood Count | Office | 396 | 283 | $9.52 | $3,770 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 365 | 73 | $4.66 | $1,699 |
| 80061 Clinical Chemistry | Office | 361 | 255 | $13.12 | $4,736 |
| 84439 Clinical Chemistry | Office | 348 | 277 | $8.82 | $3,071 |
| 84443 Clinical Chemistry | Office | 347 | 277 | $16.43 | $5,702 |
| 82306 Clinical Chemistry | Office | 311 | 262 | $29.01 | $9,022 |
| 83970 Clinical Chemistry | Office | 218 | 193 | $40.30 | $8,786 |
| 96372 Injection Administration | Office | 206 | 106 | $11.90 | $2,451 |
| 80048 Clinical Chemistry | Office | 190 | 168 | $8.29 | $1,575 |
| 82043 Clinical Chemistry | Office | 95 | 94 | $5.61 | $533 |
By year: 2022 $430K for 21,423 services; 2023 $434K for 20,824 services; 2024 $420K for 17,440 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 925 | 610 | $8.63 | $7,983 |
| 80053 Clinical Chemistry | 416 | 307 | $10.33 | $4,298 |
| 83036 Blood Count | 396 | 283 | $9.52 | $3,770 |
| 80061 Clinical Chemistry | 361 | 255 | $13.12 | $4,736 |
| 84439 Clinical Chemistry | 348 | 277 | $8.82 | $3,071 |
| 84443 Clinical Chemistry | 347 | 277 | $16.43 | $5,702 |
| 82306 Clinical Chemistry | 311 | 262 | $29.01 | $9,022 |
| 83970 Clinical Chemistry | 218 | 193 | $40.30 | $8,786 |
| 80048 Clinical Chemistry | 190 | 168 | $8.29 | $1,575 |
| 82043 Clinical Chemistry | 95 | 94 | $5.61 | $533 |
Medicare prescription drug claims, 2024
In 2024, the drug Chee-Yeung Chan prescribed most often to Medicare patients was Levothyroxine Sodium, with 884 prescriptions and refills. In total Chee-Yeung Chan wrote 8,799 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 884 | 2,313 | 220 | $12K |
| Alendronate Sodium Generic | 618 | 1,545 | 177 | $5,951 |
| Glipizide Er Glipizide | 600 | 1,640 | 163 | $14K |
| Metformin Hcl Generic | 595 | 1,604 | 163 | $5,548 |
| Ozempic Semaglutide | 570 | 1,156 | 139 | $1.1M |
| Synthroid Levothyroxine Sodium | 411 | 1,173 | 109 | $35K |
| Atorvastatin Calcium Generic | 387 | 1,126 | 119 | $4,691 |
| Mounjaro Tirzepatide | 327 | 443 | 61 | $465K |
| Metformin Hcl Er Metformin Hcl | 321 | 911 | 93 | $4,477 |
| Jardiance Empagliflozin | 215 | 529 | 53 | $305K |
| Losartan Potassium Generic | 204 | 558 | 53 | $2,191 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 201 | 517 | 74 | $17K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 194 | 474 | 65 | $35K |
| Trulicity Dulaglutide | 150 | 248 | 35 | $241K |
| Lisinopril Generic | 115 | 313 | 30 | $1,056 |
Brand drugs: 3,087 claims; generic drugs: 5,257 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Chee-Yeung Chan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.